DTC
VERA icon

Deep Track Capital’s Vera Therapeutics VERA Stock Holding History

Deep Track Capital’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$172M Sell
4,000,000
-106,067
-3% -$3.95M 2.5% 17
2026
Q1 		$165M Buy
4,106,067
+1,284,932
+46% +$55.4M 2.7% 10
2025
Q4 		$143M Buy
+2,821,135
New +$100M 2.55% 12

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deep Track Capital's VERA Position: Q2 2026 in Review

Deep Track Capital reduced its Vera Therapeutics (VERA) stake by 2.6% in Q2 2026, selling an estimated $3.95M and leaving 4,000,000 shares worth $172M. The position accounts for 2.5% of the portfolio, ranked #17.

Deep Track Capital first reported a position in VERA in Q4 2025 and has held it in 3 quarters since. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Deep Track Capital held 4,000,000 shares of Vera Therapeutics worth $172M as of Q2 2026.
  • Deep Track Capital sold 106,067 Vera Therapeutics shares in Q2 2026, an estimated $3.95M.
  • Vera Therapeutics made up 2.5% of Deep Track Capital's portfolio in Q2 2026, its #17 holding.
  • Deep Track Capital first reported a position in Vera Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.